Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -1,594 | 0 | N/A |
| Depreciation Amortization | 5 | 0 | N/A |
| Accounts receivable | -1 | N/A | N/A |
| Other Working Capital | -225 | 0 | N/A |
| Other Operating Activity | 252 | 0 | 0 |
| Operating Cash Flow | $-1,563 | $0 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3 | 0 | N/A |
| Investing Cash Flow | $-3 | $0 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1,505 | N/A | N/A |
| Financing Cash Flow | $1,505 | $0 | $N/A |
| Exchange Rate Effect | 24 | 0 | N/A |
| Beginning Cash Position | 204 | 0 | N/A |
| End Cash Position | 166 | 0 | N/A |
| Net Cash Flow | $-38 | $0 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,563 | 0 | N/A |
| Capital Expenditure | -3 | N/A | N/A |
| Free Cash Flow | -1,567 | 0 | 0 |